Quality metrics for pharma manufacturing is back in a big way, with FDA pledging to 'objectively rate' firms
After the FDA signaled an interest last month in returning to its hotly-contested quality metrics program for pharma manufacturers, the agency this week outlined what …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
